Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.58 - $1.13 $15,833 - $30,848
-27,300 Reduced 97.85%
600 $0
Q4 2021

Feb 02, 2022

SELL
$1.66 - $2.64 $144 - $229
-87 Reduced 0.31%
27,900 $46,000
Q3 2021

Nov 02, 2021

SELL
$2.58 - $3.36 $8,557 - $11,145
-3,317 Reduced 10.6%
27,987 $75,000
Q2 2021

Aug 02, 2021

BUY
$2.7 - $3.81 $1,090 - $1,539
404 Added 1.31%
31,304 $104,000
Q1 2021

May 11, 2021

BUY
$3.02 - $5.16 $44,092 - $75,336
14,600 Added 89.57%
30,900 $103,000
Q3 2018

Nov 07, 2018

SELL
$5.71 - $7.58 $11,420 - $15,160
-2,000 Reduced 10.93%
16,300 $97,000
Q2 2018

Aug 10, 2018

BUY
$6.68 - $11.0 $122,244 - $201,300
18,300 New
18,300 $126,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $23.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.